Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study Meeting Abstract
| Authors: | Straus, D. J.; Dlugosz-Danecka, M.; Alekseev, S.; Illes, A.; Picardi, M.; Lech-Maranda, E.; Feldman, T.; Savage, K. J.; Smolewski, P.; Bartlett, N. L.; Gallamini, A.; Walewski, J. A.; Ramchandren, R.; Zinzani, P. L.; Connors, J. M.; Jolin, H.; Liu, R.; Fenton, K.; Fanale, M.; Radford, J. A. |
| Abstract Title: | Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 432s |
| Language: | English |
| ACCESSION: | WOS:000487345806294 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.7532 |
| Notes: | Meeting Abstract: 7532 -- Source: Wos |
